文献速递肝病

H19通过阻止ZEB1介导的上皮细胞黏附分子抑制促进胆汁淤积性肝纤维化

H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule.
PubMed 文献 · Hepatology · 2017-08-26

在小鼠中,肝内过表达H19RNA加重胆管结扎诱导的肝纤维化,伴血清丙氨酸氨基转移酶、天冬氨酸氨基转移酶、胆红素及胆汁酸水平升高。机制上H19RNA与ZEB1蛋白相互作用,阻止ZEB1结合EpCAM启动子,从而上调EpCAM;过表达ZEB1或敲低EpCAM可减轻H19诱导的纤维化。

要点

  • 肝内过表达H19RNA加重胆管结扎诱导的小鼠肝纤维化。
  • H19RNA与ZEB1蛋白结合,阻止ZEB1抑制EpCAM启动子活性。
  • 过表达ZEB1或敲低EpCAM可减轻H19诱导的纤维化。

核心结论

  • 小鼠肝内H19RNA的激活通过ZEB1/EpCAM信号通路促进胆汁淤积性肝纤维化。

研究设计与样本

  • 基于小鼠胆汁酸稳态破坏诱导肝长链非编码RNA H19表达的发现,研究H19在胆汁淤积性肝纤维化中的作用。

主要发现

  • H19-BDL小鼠较null-BDL小鼠肝纤维化加重,血清丙氨酸氨基转移酶、天冬氨酸氨基转移酶、胆红素和胆汁酸水平升高。
  • H19-BDL小鼠较null-BDL小鼠肝纤维化、炎症和胆管增生相关基因增加,而胆汁酸合成相关基因减少。
  • H19-BDL小鼠肝和脾中CD3+γδ+、产生白细胞介素-4及白细胞介素-17的CD4+和CD8+免疫细胞群显著富集。
  • H19下调肝内ZEB1,上调EpCAM和SRY盒9表达;ZEB1抑制EpCAM启动子活性和基因转录,H19RNA与ZEB1蛋白相互作用阻止其结合EpCAM启动子。
  • 肝内过表达ZEB1或敲低EpCAM减轻H19诱导的纤维化,H19-/-小鼠中亦减轻纤维化;H19RNA在小鼠小胆管细胞中被胆汁酸显著诱导,在大胆管细胞中诱导程度较低。

关键数值与推荐

  • 在原发性硬化性胆管炎和原发性胆汁性肝硬化肝标本中,H19RNA和EpCAM上调与ZEB1下调呈正相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Based on our recent finding that disruption of bile acid (BA) homeostasis in mice results in the induction of hepatic long noncoding RNA H19 expression, we sought to elucidate the role of H19 in cholestatic liver fibrosis. Hepatic overexpression of H19RNA augmented bile duct ligation (BDL)-induced liver fibrosis, which was accompanied by the elevation of serum alanine aminotransferase, aspartate aminotransferase, bilirubin, and BA levels. Multiple genes related to liver fibrosis, inflammation, and biliary hyperplasia were increased in H19-BDL versus null-BDL mice, whereas genes in BA synthesis were decreased. Livers and spleens of H19-BDL mice showed significant enrichment of CD3+γδ+, interleukin-4, and interleukin-17 producing CD4+ and CD8+ immune cell populations. H19 down-regulated hepatic zinc finger E-box-binding homeobox 1 (ZEB1) but up-regulated epithelial cell adhesion molecule (EpCAM) and SRY (sex determining region Y)-box 9 expression. Mechanistically, ZEB1 repressed EpCAM promoter activity and gene transcription. H19RNA impeded ZEB1's inhibitory action by interacting with ZEB1 protein to prevent its binding to the EpCAM promoter. Hepatic overexpression of ZEB1 or knockdown of EpCAM diminished H19-induced fibrosis; the latter was also prevented in H19-/- mice. H19RNA was markedly induced by bile acids in mouse small cholangiocytes and to a lesser extent in mouse large cholangiocytes. The up-regulation of H19RNA and EpCAM correlated positively with the down-regulation of ZEB1 in primary sclerosing cholangitis and primary biliary cirrhosis liver specimens. CONCLUSION: The activation of hepatic H19RNA promoted cholestatic liver fibrosis in mice through the ZEB1/EpCAM signaling pathway. (Hepatology 2017;66:1183-1196).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Song Y, Liu C, Liu X, et al. H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule. Hepatology. 2017. PMID: 28407375. doi:10.1002/hep.29209

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。